Reiss-Clark Cindy has filed 15 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 246 shares of WEST PHARMACEUTICAL SERVICES INC ($WST) on February 18, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Common Stock | 246 | $211.00 | 5,130.5080 | 73,700,000 | 5.04% | 0.00% |
| Feb. 18, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | F | Common Stock | 83 | $211.00 | 5,047.3290 | 73,700,000 | 1.62% | 0.00% |
| Feb. 18, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | A | Stock Option (Right to Buy) | 1162 | $0.00 | 1,162.0000 | 73,700,000 | 9999.99% | 0.00% |
| Feb. 18, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | A | Rst. Stock Unit | 503 | $0.00 | 503.0000 | 73,700,000 | 9999.99% | 0.00% |
| Feb. 20, 2024 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | A | Common Stock | 551 | $0.00 | 4,884.3460 | 75,300,000 | 12.72% | 0.00% |
| Feb. 20, 2024 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | A | Stock Options (Right to Buy) | 2411 | $0.00 | 2,411.0000 | 75,300,000 | 9999.99% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Common Stock | 1112 | $173.22 | 5,432.1611 | 75,800,000 | 25.74% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Common Stock | 1588 | $274.29 | 7,020.1611 | 75,800,000 | 29.23% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Common Stock | 777 | $369.13 | 7,797.1611 | 75,800,000 | 11.07% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | S | Common Stock | 3477 | $393.34 | 4,320.1611 | 75,800,000 | 44.59% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Stock Options (Right to buy) | 777 | $393.34 | 2,331.0000 | 75,800,000 | 25.00% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Stock Options (Right to buy) | 1588 | $393.34 | 1,588.0000 | 75,800,000 | 50.00% | 0.00% |
| Aug. 22, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Chief Commercial Officer | M | Stock Options (Right to buy) | 1112 | $393.34 | 1,756.0000 | 75,800,000 | 38.77% | 0.00% |
| Feb. 21, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Senior Vice President | A | Common Stock | 970 | $306.68 | 4,320.1611 | 75,800,000 | 28.95% | 0.00% |
| Feb. 21, 2023 | WEST PHARMACEUTICAL SERVICES INC | $WST | Reiss-Clark Cindy | Senior Vice President | A | Stock Options (Right to buy) | 2988 | $0.00 | 2,988.0000 | 75,800,000 | 9999.99% | 0.00% |